BeStock  

Evotec EVO

US equityMarket cap rank #3614Drug Manufacturers - Specialty & Generic
$1.32 −$0.13 (-8.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.34 +1.52%
Open$1.38
Prev close$1.45
Day range$1.32 – $1.38
Volume77.6K
Market cap$469.11M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€164.93M+0.6% YoY
Operating profit-€27.12M+39.2% YoY
Net profit-€26.74M+37.9% YoY
Diluted EPS-€0.08+37.5% YoY
Free cash flow-€51.92M+41.6% YoY
Operating cash flow-€43.91M

Revenue, last 8 quarters

€221.2MDec '24€200.0MMar '25€171.2MJun '25€163.9MSep '25€253.3MDec '25€156.6MMar '26€143.5MJun '26€164.9MSep '26

Net profit, last 8 quarters

€-40.8MDec '24€-31.6MMar '25€-43.5MJun '25€-43.1MSep '25€14.6MDec '25€-121.9MMar '26€-46.6MJun '26€-26.7MSep '26

Diluted EPS by quarter

-0.12Dec '24-0.09Mar '25-0.12Jun '25-0.12Sep '250.05Dec '25-0.35Mar '26-0.13Jun '26-0.08Sep '26

Free cash flow by quarter

€49.1MDec '24€-53.6MMar '25€2.7MJun '25€-89.0MSep '25€48.1MDec '25€-14.7MMar '26€-118.2MJun '26€-51.9MSep '26

Annual revenue

€500.9MFY20€618.0MFY21€751.4MFY22€781.4MFY23€797.0MFY24€788.4MFY25

Profitability & balance sheet

Gross margin10.3%
Operating margin-17.5%
Net margin-25.2%
Return on equity-25.1%
Return on assets-11.0%
Return on invested capital-14.5%
Current ratio2.32
Liabilities / assets57.4%
Cash & investments€418.48M
Total debt€417.21M
Net cash (debt)€1.27M

Where the revenue comes from

Quarter 2026/Q1

By business line

  • Discovery & Preclinical Development (D&PD)€119.90M 76.5%
  • Just - Evotec Biologics (JEB)€36.84M 23.5%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Income statement

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Revenue as Reported €164.93M €143.48M €156.64M €788.37M €253.27M
Total Operating Revenue €164.93M €143.48M €156.64M €788.37M €253.27M
Cost of Revenue €145.13M €145.06M €158.21M €674.15M €196.17M
Gross Profit €19.80M -€1.58M -€1.57M €114.22M €57.11M
Operating Expense €46.91M €87.74M €44.85M €170.04M €19.90M
Selling and Admin Expenses €38.78M €39.29M €43.79M €175.97M €37.57M
Research & Development €9.34M €10.26M €10.08M €37.51M -€4.75M
Other Operating Expenses -€1.22M €38.20M -€9.02M -€1.83M €28.69M
Operating Profit -€27.12M -€89.32M -€46.42M -€55.82M €37.21M
Net Non-Operating Interest Income (Expense) -€1.20M -€2.79M -€790,000.00 -€10.02M -€2.60M
Non-Operating Interest Income €2.71M €183,000.00 €1.79M €4.42M €1.16M
Non-Operating Interest Expense €3.91M €2.97M €2.58M €14.44M €3.76M
Other Income (Expense) €6.29M €43.99M -€74.97M -€20.93M -€5.15M
Gain on Sale of Security -€1.57M €69.84M €192,000.00 -€677,000.00 -€2.42M
Earnings from Equity Interest -€370,000.00 -€869,000.00 -€286,000.00 -€1.09M -€349,000.00
Special Income (Charges) €7.00M -€23.95M -€74.97M -€399,000.00 -€1.14M
-Less:Restructuring and Mergern & Acquisition -€7.00M €23.95M €74.97M €633,000.00 €1.37M
Other Non-Operating Income (Expenses) €1.23M -€1.02M €100,000.00 -€18.77M -€1.24M
Pretax Profit -€22.02M -€48.12M -€122.18M -€86.77M €29.46M
Tax €4.72M -€1.47M -€244,000.00 €16.75M €14.84M
Net Profit -€26.74M -€46.65M -€121.94M -€103.52M €14.62M
Profit from Continuing Operations -€26.74M -€46.65M -€121.94M -€103.52M €14.62M
Net Income to Parent Company -€26.74M -€46.65M -€121.94M -€103.52M €14.62M
Net Income to Common Stockholders -€26.74M -€46.65M -€121.94M -€103.52M €14.62M
Basic EPS -€0.08 -€0.13 -€0.34 -€0.29 €0.05
Diluted EPS -€0.08 -€0.13 -€0.35 -€0.29 €0.05
-Selling & Marketing Expense – – – €17.38M –
-General & Admin Expense – – – €158.60M –
Other Taxes – – – -€41.61M –
-Less:Impairment of Capital Assets – – – €0.00 –
-Less:Other Special Charges – – – €1.68M –
-Gain on Sale Of Business – – – €1.91M –

Balance sheet

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Total Assets €1.50B €1.57B €1.64B €1.71B €1.71B
Total Current Assets €663.26M €728.89M €711.28M €762.95M €762.95M
Cash and Cash Equivalents & Short-Term Investments €418.48M €483.62M €463.78M €463.02M €463.02M
-Cash and Cash Equivalents €299.01M €348.36M €387.91M €401.79M €401.79M
-Short Term Investments €119.47M €135.26M €75.87M €61.23M €61.23M
Receivables €171.27M €166.46M €167.05M €213.51M €213.51M
-Accounts Receivable €108.56M €96.35M €98.26M €135.96M €135.96M
-Taxes Receivable €34.03M €36.82M €33.47M €49.25M €49.25M
-Other Receivables €28.68M €33.29M €35.32M €28.30M €28.30M
Inventory €37.71M €38.56M €32.98M €29.32M €29.32M
Other Current Assets €35.80M €40.25M €43.55M €709,000.00 €709,000.00
Total Non-Current Assets €841.71M €845.09M €928.53M €951.00M €951.00M
Net PPE €444.54M €449.77M €530.84M €554.63M €554.63M
Investments and Advances €39.21M €42.55M €53.31M €52.63M €52.63M
-Available for Sale Securities €36.11M €39.07M €48.97M €48.00M €48.00M
-Long Term Equity Investment €3.11M €3.48M €4.35M €4.63M €4.63M
Non Current Accounts Receivables €49.25M €43.27M €36.87M €36.35M €36.35M
Goodwill and Other Intangible Assets €307.23M €306.51M €305.41M €303.94M €303.94M
Non-Current Deferred Assets €113,000.00 €1.89M €1.69M €2.95M €2.95M
Other Non-Current Assets €1.36M €1.10M €417,000.00 €508,000.00 €508,000.00
Total Liabilities €863.31M €908.40M €940.19M €900.24M €900.24M
Total Current Liabilities €285.64M €312.46M €423.37M €368.07M €368.07M
Payables €57.29M €58.03M €64.42M €81.03M €81.03M
-Accounts Payable €48.58M €49.13M €54.90M €64.76M €64.76M
-Total Tax Payable €8.71M €8.90M €9.52M €16.27M €16.27M
Short-Term Debt and Capital Lease Obligation €64.61M €61.54M €88.62M €103.68M €103.68M
Current Provisions €74.26M €92.76M €130.83M €58.54M €58.54M
Current Deferred Liabilities €64.08M €72.53M €114.69M €108.07M €108.07M
Other Current Liabilities €25.41M €27.60M €24.83M €11.10M €11.10M
Total Non-Current Liabilities €577.67M €595.94M €516.82M €532.17M €532.17M
Long Term Debt and Capital Lease Obligation €417.21M €414.32M €298.85M €344.01M €344.01M
Non-Current Liabilities €27.38M €26.23M €64.17M €18.04M €18.04M
Non-Current Deferred Liabilities €133.08M €154.05M €152.46M €168.41M €168.41M
Other Non-Current Liabilities -€1,000.00 €1.34M €1.34M €1.72M €1.72M
Total Equity €641.66M €665.58M €699.62M €813.70M €813.70M
Stockholders' Equity €641.66M €665.58M €699.62M €813.70M €813.70M
Capital Stock €177.91M €177.91M €177.88M €177.78M €177.78M
-Common Stock €177.91M €177.91M €177.88M €177.78M €177.78M
Additional Paid-In Capital €1.47B €1.47B €1.46B €1.46B €1.46B
Retained Earnings -€971.22M -€944.47M -€897.82M -€775.89M -€775.89M
Less: Treasury Stock -€531,000.00 -€980,000.00 -€1.14M -€1.55M -€1.55M
Gains/Losses Not Affecting Retained Earnings -€35.18M -€35.77M -€38.32M -€45.11M -€45.11M
Other Equity Interests -€1,000.00 -€1,000.00 – – –
-Long Term Debt – €414.32M €298.85M €344.01M €344.01M
Prepaid Assets – – – €18.97M €18.97M
Restricted Cash – – – €33.59M €33.59M
-Gross PPE – – – €1.07B €1.07B
-Accumulated Depreciation – – – -€519.54M -€519.54M
-Goodwill – – – €272.37M €272.37M
-Other Intangible Assets – – – €31.57M €31.57M
-Current Debt – – – €81.50M €81.50M
-Current Capital Lease Obligation – – – €22.18M €22.18M

Cash flow

Line item 2026 Q3
(EUR)
2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
Operating Cash Flow -€43.91M -€107.19M -€3.92M -€9.18M €63.63M
Net cash flow from continuing operations -€43.91M -€107.19M -€3.92M -€9.18M €63.63M
Net Income from Continuing Operations -€26.74M -€46.65M -€121.94M -€103.52M €14.62M
Other Non-Cash Items €37.81M €22.88M €46.53M €28.99M -€83.42M
Change in Working Capital -€54.98M -€83.42M €71.49M -€60.80M €6.27M
Net cash flow from investing €7.73M €19.52M -€12.43M €171.59M €222.38M
Net Cash Flow from Continuing Investing Activities €7.72M €19.52M -€12.44M €171.59M €222.38M
Net PPE Purchase and Sale -€5.94M -€9.11M -€4.08M -€72.33M -€14.51M
Net Intangibles Purchase and Sale -€2.13M -€1.90M -€6.63M -€10.08M -€824,000.00
Net Business Purchase and Sale €89.39M -€2.27M -€4.50M €216.86M €231.38M
Net Investment Purchase and Sale -€75.42M €30.52M €905,000.00 €31.97M €5.48M
Net Other Investing Changes €2,000.00 -€2,000.00 €1,000.00 €1,000.00 –
Financing Cash Flow -€10.75M €52.86M -€19.09M -€37.63M -€46.23M
Net Cash Flow from Continuing Financing Activities -€10.75M €52.86M -€19.09M -€37.63M -€46.23M
Net Issuance Payments Of Debt -€10.64M €55.75M -€19.09M -€29.42M -€42.44M
Cash Dividends Paid €0.00 €0.00 €0.00 €0.00 €0.00
Proceeds from Stock Option Exercised €0.00 €32,000.00 €99,000.00 €225,000.00 €7,000.00
Ending Cash Balance €299.01M €348.36M €387.91M €418.52M €418.52M
Net Change in Cash -€46.94M -€34.81M -€35.44M €124.78M €239.78M
Beginning Cash Balance €348.36M €387.91M €418.52M €306.39M €179.27M
Effect of Exchange Rate Changes -€2.41M -€4.75M €4.84M -€12.65M -€539,000.00
Free Cash Flow -€51.92M -€118.20M -€14.70M -€91.80M €48.11M
Net Other Financing Charges – – -€1,000.00 -€1.46M -€99,000.00
Gain/Loss from Continuing Operations – – – -€7.29M –
Depreciation & Depletion & Amortization – – – €99.48M –
Deferred Tax – – – €16.75M –
-Change in Receivables – – – -€28.73M –
-Change in Inventory – – – -€9.56M –
-Change in Payables and Accrued Expense – – – -€7.30M –
-Change In Other Working Capital – – – -€15.21M –
Net Common Stock Issuance – – – -€1.55M –

Discussion

No comments yet — be the first to weigh in on EVO.

Sign in to join the discussion.

Scroll to Top